http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201429474-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate | 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5c747d93a2a823c41948e42d9c3a95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95f87781f0901eb12f139ad8138543ec |
publicationDate | 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201429474-A |
titleOfInvention | Cancer treatment method by combination of medicaments |
abstract | The subject of the present invention is to seek a method for increasing the efficacy of a taxane-based antitumor agent against various tumors. The solution of the present invention is a result of reviewing the method for enhancing the antitumor effect of a taxane-based antitumor agent, and confirms that it contains N2-(2E)-3-(4-chlorophenyl)-2- Propylmercapto]-N-[2-carbonyl-2-(4-{[6-(trifluoromethyl)pyrimidin-4-yl]oxy}piperidin-1-yl)ethyl]-3-pyridine- The present invention can be accomplished by enhancing the antitumor effect of a taxane-based antitumor agent by using 2-methyl-L-alanamine (FK330) or a salt thereof as a therapeutic composition for cancer. In other words, the present application relates to a cancer therapeutic composition containing FK330 or a salt thereof as an active ingredient in combination with one or more antitumor agents selected from the group consisting of taxane-based antitumor agents. The form is a therapeutic composition for prostate cancer or ovarian cancer. |
priorityDate | 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.